AR044339A1 - Composicion de vacuna aviar para la proteccion de aves de corral contra enfermedades e infeccion causadas por e. coli y salmonella - Google Patents

Composicion de vacuna aviar para la proteccion de aves de corral contra enfermedades e infeccion causadas por e. coli y salmonella

Info

Publication number
AR044339A1
AR044339A1 ARP040101655A ARP040101655A AR044339A1 AR 044339 A1 AR044339 A1 AR 044339A1 AR P040101655 A ARP040101655 A AR P040101655A AR P040101655 A ARP040101655 A AR P040101655A AR 044339 A1 AR044339 A1 AR 044339A1
Authority
AR
Argentina
Prior art keywords
coli
salmonella
vaccine
aviar
composition
Prior art date
Application number
ARP040101655A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of AR044339A1 publication Critical patent/AR044339A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0275—Salmonella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • C12N9/1092—3-Phosphoshikimate 1-carboxyvinyltransferase (2.5.1.19), i.e. 5-enolpyruvylshikimate-3-phosphate synthase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Composición de vacuna que comprende una cantidad inmunógenamente eficaz de una combinación de un microorganismo mutante de deleción genética de S. typhimurium y un microorganismo mutante de deleción genética de E. coli y un portador farmacológicamente aceptable, adecuada para la aplicación masiva a aves de corral. Método seguro y eficaz para proteger aves de corral contra las devastaciones de la infección y enfermedad por E. coli y Salmonella.
ARP040101655A 2003-05-14 2004-05-14 Composicion de vacuna aviar para la proteccion de aves de corral contra enfermedades e infeccion causadas por e. coli y salmonella AR044339A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47047003P 2003-05-14 2003-05-14

Publications (1)

Publication Number Publication Date
AR044339A1 true AR044339A1 (es) 2005-09-07

Family

ID=33476713

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040101655A AR044339A1 (es) 2003-05-14 2004-05-14 Composicion de vacuna aviar para la proteccion de aves de corral contra enfermedades e infeccion causadas por e. coli y salmonella

Country Status (14)

Country Link
US (1) US7297338B2 (es)
EP (1) EP1622643A2 (es)
JP (2) JP5500762B2 (es)
KR (1) KR101150318B1 (es)
CN (2) CN102274495A (es)
AR (1) AR044339A1 (es)
AU (1) AU2004240585B2 (es)
BR (1) BRPI0410355B1 (es)
CA (1) CA2524939C (es)
MX (1) MXPA05012219A (es)
NZ (1) NZ543558A (es)
TW (1) TW200503755A (es)
WO (1) WO2004103401A2 (es)
ZA (1) ZA200509982B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7357935B2 (en) * 2003-05-14 2008-04-15 Wyeth Avian E. coli vaccine for protection against colibacillosis
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
PE20110480A1 (es) 2008-09-26 2011-07-01 Ambrx Inc Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales
CN102140430B (zh) * 2011-01-13 2013-10-23 河南科技大学 一种不含抗性标记的鼠伤寒沙门氏菌基因缺失突变菌株、疫苗及应用
KR101518872B1 (ko) * 2013-05-14 2015-05-22 대한민국(관리부서 : 농림축산식품부 농림축산검역본부) 가금의 세균성 전신성 질병 원인균 진단용 프라이머 세트 및 상기 프라이머 세트를 포함하는 진단 키트
CN104711365B (zh) * 2015-04-02 2018-06-12 青岛康伦生物科技有限公司 沙门菌和大肠杆菌o78多重pcr快速检测的试剂盒
CN112618706B (zh) * 2020-11-21 2021-09-14 青岛博霖生物科技有限公司 沙门氏菌、鸭疫里默氏杆菌、大肠埃希氏杆菌病三联疫苗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US400958A (en) * 1889-04-09 Leading-in apparatus for conduits
US650733A (en) * 1899-06-23 1900-05-29 William A Shaw Fire-escape.
GB8912330D0 (en) 1989-05-30 1989-07-12 Wellcome Found Live vaccines
JPH07206705A (ja) 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
GB9806449D0 (en) * 1998-03-25 1998-05-27 Peptide Therapeutics Ltd Attenuated bacteria useful in vaccines
US7357935B2 (en) * 2003-05-14 2008-04-15 Wyeth Avian E. coli vaccine for protection against colibacillosis

Also Published As

Publication number Publication date
JP2012131796A (ja) 2012-07-12
US20040234550A1 (en) 2004-11-25
EP1622643A2 (en) 2006-02-08
CA2524939A1 (en) 2004-12-02
BRPI0410355B1 (pt) 2016-09-13
MXPA05012219A (es) 2006-02-08
AU2004240585B2 (en) 2010-08-19
CN102274495A (zh) 2011-12-14
KR20060012001A (ko) 2006-02-06
BRPI0410355A (pt) 2006-07-04
TW200503755A (en) 2005-02-01
AU2004240585A1 (en) 2004-12-02
CA2524939C (en) 2012-12-04
ZA200509982B (en) 2011-05-25
JP5500762B2 (ja) 2014-05-21
CN1787836A (zh) 2006-06-14
NZ543558A (en) 2008-02-29
JP2006528979A (ja) 2006-12-28
WO2004103401A2 (en) 2004-12-02
KR101150318B1 (ko) 2012-06-08
US7297338B2 (en) 2007-11-20
WO2004103401A3 (en) 2005-02-10

Similar Documents

Publication Publication Date Title
CY1107188T1 (el) Εμβολιο ε. coli πτηνου για την προστασια εναντι κολοβακτηριωσης
BR0110810B1 (pt) derivados de éter fenil-propargílico, processo para a preparação dos mesmos, composição para controle e proteção contra organismos fúngicos, uso dos referidos derivados e método de controle e prevenção de uma infestação de plantas de cultura por organismos fúngicos
BR0112928A (pt) Vacinas para proteção de amplo espectro contra doenças causadas por neisseria meningitidis
ATE358722T1 (de) Kälte-adaptierte pferde influenza-viren
HN1999000183A (es) Preparado farmaceuticos de moxifloxacina
DK1299130T3 (da) Fremgangsmåde til behandling og forebyggelse af smitsomme sygdomme
CO5611162A2 (es) Metodos para prevenir enfermedades reproductivas en el ganado vacuno
WO2001060849A3 (en) Cold-adapted equine influenza viruses
AR043824A1 (es) Composiciones y metodo para tratar las infecciones microbianas y parasitarias en el ganado y otros animales
AR128074A1 (es) Composición farmacéutica inyectable para el tratamiento de enfermedades respiratorias en animales
CR8638A (es) Vacuna agalactiae estreptococos
DE602007005672D1 (de) -stamms, die diesen enthalten, sowie verfahren für die biologische dipterenbekämpfung
DE60336927D1 (es)
TW200503755A (en) Avian vaccine composition for the protection of poultry against disease and infection caused by e. coli and salmonella
BR9811319A (pt) Método para proteger um animal contra umadoença crÈnica
AU4930001A (en) Cold-adapted equine influenza viruses
BR0209251A (pt) Vacina contra vìrus da febre aftosa
Gudmundsdottir et al. Aeromonas salmonicida and A. hydrophila.
MX2023010693A (es) Metodo y composicion de una vacuna para enfermedades bacterianas en invertebrados.
UY29445A1 (es) Composiciones para la transmisión transmucosa oral de la metformina
ECSP045083A (es) Nueva enfermedad bacteriana de las aves de corral
ES2042718T3 (es) Procedimiento para la preparacion de una vacuna para proteger aves de corral contra septicemia producida por e. coli.
ES2066206T3 (es) Utilizacion de adenilciclasa como vacunas contra bordetella.
AR009650A1 (es) Mycoplasma synoviae atenuado vivo, su uso, un cultivo microbiologico que lo comprende, una vacuna bacteriana atenuada viva para la proteccion de las aves de corral contra la infeccion por mycoplasma synoviae y un metodo para preparar dicha vacuna.
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok

Legal Events

Date Code Title Description
FA Abandonment or withdrawal